|
Recent Developments |
|
14-MAY-18
JB Chemicals & Pharmaceuticals' API manufacturing facility at Panoli, Gujarat has successfully passed periodical inspection by US FDA with two minor procedural observations.
13-DEC-17
JB Chemicals & Pharmaceuticals has received USFDA approval for its Supplementary Abbreviated New Drug Application (sANDA) for Atenolol Tablets USP 25 mg. 50 mg. and 100 mg. (anti-hypertensive) manufactured using company's own bulk drug (API).
06-JAN-... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Dec-2017(9) | 31-Mar-2017(12) | 31-Mar-2016(12) | | Net sales | 9385.07 | 11933.09 | 11292.68 | | Other Income | 215.54 | 462.15 | 529.24 | | Total Income | 9600.61 | 12395.24 | 11821.92 | | Cost of goods sold | 7892.39 | 10162.12 | 9355.73 | | OPBDIT | 1708.22 | 2233.12 | 2466.19 | | PAT | 1059.42 | 1729.65 | 1763.88 | | Gross Block | - | - | - | | Equity capital | - | - | 169.64 | | EPS (Rs.) | - | - | - | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | - | - | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 17.8 | 18.0 | 20.9 | | Net margin (% of OI) | 11.0 | 14.0 | 14.9 |
|
|
Detailed Financials
|
|
|
|
|
